Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Trading Statement

16 Mar 2022 07:00

Β 

Pre-close Trading Statement

FY2022 finishes with a robust return to trading driven by strong consumer demand

FY2022 Results and Capital Markets Day scheduled for 17 May 2022

Dublin, London | 16 March 2022: C&C Group plc (β€˜C&C’ or the 'Group’), a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits and soft drinks across the UK and Ireland, today provides an update on recent trading performance and profit guidance for the financial year ended 28 February 2022 (β€˜FY2022’).

C&C outlined in our 7 January 2022 trading update that the operating profit outcome for H2 FY2022 had been affected as result of the renewed government restrictions on the hospitality industry, particularly the key Christmas trading period. Consequently, C&C expects to report a FY2022 operating profit in the range of €45-47m1. In January 2022, restrictions in our core markets of the UK and Ireland were eased and we are pleased to see positive trading in the on-trade. We were back trading with 81% of direct delivered outlets in February 2022 versus February 2020, with corresponding volumes at 68% and momentum building as outlets continue to re-open.

Our focus continues to be on ensuring that we provide market leading service for our brands and partnership brands to our customers as trading recovers. We are operating in an evolving inflationary cost environment, however we are afforded a degree of protection through our successfully executed €18m cost reduction plan, our recent price increases and input cost hedging. Over and above effective management of both operating and input costs, our well invested network and technology-led system continues to provide the platform for C&C to be the pre-eminent brand led drinks distributor in the UK and Ireland.

Throughout the year, we focused on liquidity management and net debt reduction. Underlining our strong balance sheet position, we expect net debt to be approximately €263m1,2 at the end of FY2022 compared with €442m2,3 at the end of FY2021. This significant reduction in net debt, together with an improving business performance, will substantially enhance our financial flexibility and enable C&C to deliver our strategic objectives, to drive growth for C&C and returns for shareholders.

FY2022 Results and Capital Markets Day

FY2022 Results will be announced on the morning of 17 May 2022. Our Capital Markets Day has been reconvened for the afternoon of 17 May 2022, where we look forward to providing the market with further insight into the Group’s strategy, outlining our medium-term targets, capital allocation framework and sustainability agenda.

1 Unaudited financials.

2 Net debt, including the impact of IFRS 16, comprises borrowings (net of issue costs), lease liabilities capitalised less cash.

3 Reported balance sheet date.

ENDS

Contacts

C&C Group plc

Patrick McMahon, Chief Financial Officer

Ewan Robertson, Finance and Investor Relations Director

Email: ewan.robertson@candcgroup.com

FTI Consulting

Jonathan Neilan / Paddy Berkery

Tel: +353 86 231 4135 / +353 86 602 5988

Email: CandCGroup@fticonsulting.com

Novella Communications

Tim Robertson

Tel: +44 203 151 7008

Email: TimR@novella-comms.com

Forward looking statement

This document contains forward looking statements which reflect the Board of Directors’ current views and estimates. The forward looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures, the effects of a pandemic or epidemic or a natural disaster, and regulatory developments. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise any forward-looking statements other than as required by applicable laws.

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

β€’ C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent’s brands to over 40 countries worldwide.

β€’ C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

β€’ C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent’s and Bulmers Ireland brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies.

β€’ C&C Group also has a minority investment in the Admiral Taverns tenanted pub group, which owns over 1,600 pubs across England, Scotland and Wales.

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005131/en/

Copyright Business Wire 2022

Date   Source Headline
2nd Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20174:20 pmRNSDirector/PDMR Shareholding
1st Jun 20171:28 pmRNS2017 Final Dividend - Scrip Alternative
1st Jun 20179:25 amRNSTotal Voting Rights
1st Jun 20177:05 amBUSDirector Declaration
1st Jun 20177:00 amRNSBlock Listing Six Monthly Return
1st Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20177:00 amBUSDirectorate change
26th May 20176:05 pmRNSTransaction in Own Shares
26th May 20177:00 amRNSTransaction in Own Shares
25th May 20174:00 pmRNSDirector/PDMR Shareholding
23rd May 20178:59 amRNSHolding(s) in Company
19th May 20177:05 amBUSDirector Declaration
19th May 20177:00 amBUSStatement re Appointment of Non-executive Director
17th May 20177:00 amBUSFinal Results
16th May 20178:29 amRNSHolding(s) in Company
9th May 20179:23 amRNSHolding(s) in Company
8th May 20177:00 amBUSNotice of Results
2nd May 20172:10 pmRNSTotal Voting Rights
13th Apr 20175:31 pmRNSDirector/PDMR Shareholding
7th Apr 20178:52 amRNSHolding(s) in Company
3rd Apr 20175:51 pmRNSHolding(s) in Company
3rd Apr 201710:11 amRNSTransaction in Own Shares - Replacement
3rd Apr 201710:02 amRNSTotal Voting Rights
3rd Apr 20177:00 amBUSTransaction in Own Shares
31st Mar 20178:46 amRNSDirector Declaration
31st Mar 20177:00 amBUSDirectorate change
20th Mar 20179:06 amRNSHolding(s) in Company
10th Mar 20177:00 amBUSStatement re Pre-Close Trading Update
8th Mar 20174:52 pmRNSHolding(s) in Company
7th Mar 20173:00 pmBUSStatement re Notice of Pre-Close Trading Update
7th Mar 20177:00 amRNSHolding(s) in Company
1st Mar 201710:11 amRNSTotal Voting Rights
28th Feb 20174:07 pmRNSHolding(s) in Company
24th Feb 20178:59 amRNSHolding(s) in Company
16th Feb 20176:02 pmRNSDirector/PDMR Shareholding
8th Feb 201712:32 pmRNSHolding(s) in Company
8th Feb 201712:29 pmRNSHolding(s) in Company
7th Feb 20174:18 pmRNSHolding(s) in Company
1st Feb 20175:00 pmRNSHolding(s) in Company
1st Feb 201712:16 pmRNSTotal Voting Rights
3rd Jan 201710:13 amRNSTotal Voting Rights
22nd Dec 20164:30 pmRNSDirector/PDMR Shareholding
21st Dec 20162:47 pmRNSDirector/PDMR Shareholding
21st Dec 20169:00 amBUSStatement re Death of Non-Executive Director
16th Dec 20167:00 amRNSMain Securities Market Notice
14th Dec 20167:00 amRNSScrip Alternative - Additional Listing
12th Dec 20167:00 amBUSAgreement
1st Dec 201611:22 amRNSBlocklisting Six Monthly Return
1st Dec 201611:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.